Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: Newborn
Maximum Age: 2
Healthy Volunteers: t
View:

• Healthy singleton term intrauterine growth restricted (IUGR) and appropriate for gestational age (AGA) infants whose mothers are followed by the Obstetric Department of Montefiore Medical Center and who deliver at the Weiler Division of Montefiore Medical Center. Infants will be classified as IUGR if birth weight is \<10th percentile for gestational age and gender based on World Health Organization (WHO) growth curves. Infants will be classified as AGA if birth weight percentile is \>10th and \<90th percentile

• Reproductive age women, healthy enough to achieve pregnancy

• Deliver a single healthy live term infant at ≥37 weeks' gestational age (GA)

• All patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Locations
United States
New York
Jack D. Weiler Hospital
RECRUITING
The Bronx
Contact Information
Primary
Sandra Reznik, MD
sreznik@montefiore.org
718-904-2947
Time Frame
Start Date: 2018-09-01
Estimated Completion Date: 2028-03
Participants
Target number of participants: 400
Treatments
IUGR infants
Intrauterine growth restricted infants will be enrolled. There are no interventions.
AGA infants
Appropriate for gestational age infants will be enrolled. There are no interventions.
Related Therapeutic Areas
Sponsors
Collaborators: Gencove, Icahn School of Medicine at Mount Sinai, University of Wisconsin, Madison, University of California, San Francisco, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Hackensack Meridian Health Center for Discovery and Innovation
Leads: Montefiore Medical Center

This content was sourced from clinicaltrials.gov